Early Aortic Valve Intervention in Asymptomatic Severe Aortic Stenosis: A Clinical Dilemma in Evolution
European Heart Journal Open · 29.08.2025
DOI: 10.1093/ehjopen/oeaf114 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Heart Journal Open, online erschienen am 29.08.2025. Verfasst von Patrizio Lancellotti und 13 weiteren Autor:innen. Beteiligte Einrichtung: GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège Hospital, Avenue de l'Hôpital 1, 4000 Liège, Belgium. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The management of asymptomatic severe aortic stenosis (AS) has traditionally relied on watchful waiting until the onset of symptoms or left ventricular dysfunction. However, the FDA's approval of transcatheter aortic valve replacement (TAVR) with the Sapien 3 platform in May 2025, based on the EARLY TAVR trial, has intensified the debate over early intervention. This Viewpoint synthesizes evidence from randomized trials (RECOVERY, AVATAR, EVOLVED, EARLY TAVR) and registries (HAVEC, VALVENOR) to evaluate the role of early aortic valve replacement (AVR). Early intervention is associated with reductions in combined endpoints of cardiovascular hospitalizations, stroke, and mortality in selected patients, with the EARLY TAVR demonstrating a 50% reduction in major cardiovascular events. Nonetheless, evidence remains inconsistent, particularly in low-risk populations, as the EVOLVED trial showed no mortality benefit in patients with myocardial fibrosis, warranting cautious interpretation. A conservative surveillance strategy remains appropriate in some cases, supported by the low annual risk of sudden death (i.e., 0.65% per year) and ongoing concerns over valve durability and procedural risks. Given the heterogeneity of patient and valve phenotypes, a personalized risk assessment, combining clinical evaluation, biomarkers (troponin, BNP), and imaging (echocardiography, CMR), is proposed to identify high-risk patients and optimize the timing of early intervention. Expert heart team guidance is essential, and routine early intervention cannot yet be recommended. Further research is needed to refine strategies and improve outcomes in this evolving clinical landscape.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège Hospital, Avenue de l'Hôpital 1, 4000 Liège, Belgium.
- Department of Cardiology, University of Liège Hospital, Domaine Universitaire du Sart Tilman-B.35, Liège 4000, Belgium.
- Department of Cardiology, Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Rue Calmette BP245, Lille 59019, France.
- Cardiovascular Research Foundation, 1700 Broadway, 9th Floor, New York, NY, USA.
- Centrum Voor Harten Vaatziekten (CHVZ), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Avenue du Laerbeek 101, 1090 Jette, Brussels, Belgium.
- In Vivo Cellular and Molecular Imaging (ICMI) Center, Vrije Universiteit Brussel (VUB), Avenue du Laerbeek 101, 1090 Jette, Brussels, Belgium.
ORCID-Profile: Patrizio Lancellotti, Augustin Coisne, Geu-Ru Hong, Marco Moscarelli, Erwan Donal, Khalil Fattouch, Philippe Pibarot
Zitieren
APA
Lancellotti, P., Coisne, A., Cosyns, B., Dulgheru, R., Garbi, M., Hong, G. R., Hanzevacki, J. S., Moscarelli, M., Sugimoto, T., Donal, E., Fattouch, K., Habib, G., Vannan, M., & Pibarot, P. (2025). Early Aortic Valve Intervention in Asymptomatic Severe Aortic Stenosis: A Clinical Dilemma in Evolution. European Heart Journal Open. https://doi.org/10.1093/ehjopen/oeaf114
Vancouver
Lancellotti P, Coisne A, Cosyns B, Dulgheru R, Garbi M, Hong GR, et al. Early Aortic Valve Intervention in Asymptomatic Severe Aortic Stenosis: A Clinical Dilemma in Evolution. European Heart Journal Open. 2025. doi:10.1093/ehjopen/oeaf114
BibTeX
@article{Lancellotti2025,
author = {Lancellotti, Patrizio and Coisne, Augustin and Cosyns, Bernard and Dulgheru, Raluca and Garbi, Madalina and Hong, Geu-Ru and Hanzevacki, Jadranka Separovic and Moscarelli, Marco and Sugimoto, Tadafumi and Donal, Erwan and Fattouch, Khalil and Habib, Gilbert and Vannan, Mani and Pibarot, Philippe},
title = {Early Aortic Valve Intervention in Asymptomatic Severe Aortic Stenosis: A Clinical Dilemma in Evolution},
journal = {European Heart Journal Open},
year = {2025},
doi = {10.1093/ehjopen/oeaf114}
}
EUVIMED